Breaking News, Collaborations & Alliances

McMaster, Sartorius Enter Biomanufacturing Partnership

Team up to advance biomanufacturing processes with next-gen tech.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sartorius Stedim Biotech, an international partner of the biopharmaceutical industry, has entered into a partnership with McMaster University to improve manufacturing processes of antibody and virus-based treatments for diseases such as COVID-19, cancers and genetic disorders.   Using a state-of-the-art multi-column chromatography system provided by Sartorius Stedim Biotech, the McMaster team will “perfect” a process for the purification of therapeutic viruses that is more effective and cheaper ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters